Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researchers Link Cell Division and Oxygen Levels

June 13, 2011 11:44 am | News | Comments

Researchers at Johns Hopkins University report that the MCM proteins, which promote cell division, also directly control the oxygen-sensing HIF-1 protein.


LC-MS Software

June 13, 2011 8:35 am | Product Releases | Comments

Thermo Fisher Scientific Inc. introduced the TraceFinder 1.1, its latest software for clinical research laboratories performing routine, high-throughput quantitation by LC-MS.


Automated Oiler

June 13, 2011 8:32 am | Product Releases | Comments

Prior Scientific has introduced the PL220 Automatic Oiler for use with the Prior PL100/PL200 Slide Loader Systems or as a stand alone system for OEM applications.


Quintiles Working with Kareus on Development

June 13, 2011 8:24 am | News | Comments

Kareus Therapeutics SA announced a broad strategic alliance with Quintiles to progress the development of two of Kareus’ pre-clinical programs through clinical trials. Under the terms of the alliance, Quintiles will make an investment in Kareus in the seven figure range


Merck to Sell Generic Enbrel

June 13, 2011 8:04 am | News | Comments

Merck & Co. will team up with a South Korean company to study and sell a generic version of the rheumatoid arthritis and psoriasis drug Enbrel, the company said.


Vertex Licenses Hep C Drugs from Alios

June 13, 2011 8:02 am | News | Comments

Vertex Pharmaceuticals Inc. has licensed two potential hepatitis C drugs from Alios BioPharma Inc. Vertex said that it plans to start human testing of the two drugs later this year.


FDA OKs Epilepsy Treatment

June 13, 2011 7:58 am | News | Comments

GlaxoSmithKline and Valeant Pharmaceuticals said that federal regulators approved its epilepsy drug Potiga as safe and effective, following multiple delays.


Donors Promise $4B to Vaccine Fund

June 13, 2011 7:56 am | News | Comments

Donors promised to give a global vaccines body more than $4 billion to help it protect millions of children from diseases like measles, pneumonia and yellow fever.


Medicare Costs A Barrier for Cancer Meds

June 13, 2011 7:52 am | by Ricardo Alonso-Zaldivar | News | Comments

Facing a life-and-death struggle with kidney cancer, Rita Moore took her prescription for a new kind of chemotherapy pill to her local drugstore. She was stunned when the pharmacist told her the cost for a month's supply would be $2,400.


Icahn Nominates 4 Candidates to Forest Labs Board

June 13, 2011 7:48 am | News | Comments

Forest Laboratories Inc. said a fund affiliated with billionaire investor Carl Icahn, High River Limited Partnership, plans to nominate four directors to Forest's board.


Cancer Protein May Aid Radiation Therapy

June 10, 2011 10:27 am | News | Comments

Scientists at Dana-Farber Cancer Institute have uncovered a new role for a key cancer protein, a finding that could pave the way for more effective radiation treatments of a variety of tumors.


Neovacs Receives OSEO Payment for Tracker Project

June 10, 2011 10:22 am | News | Comments

Neovacs reports it has received a $2.1 milion payment from OSEO for the Tracker Project, which focuses on rheumatoid arthritis therapy.


Otonomy Releases OTO-201 Preclinical Results

June 10, 2011 10:17 am | News | Comments

Otonomy, Inc. announced preclinical results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the treatment of middle ear effusion (fluid) at the time of tympanostomy tube placement surgery.


Nicotine Receptor Plays Role in Weight Gain

June 10, 2011 10:09 am | News | Comments

Research by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, shows a specific subclass of brain nicotinic receptor is involved in nicotine’s ability to reduce food intake in rodents.


Multiplex Biomarker Assay

June 10, 2011 8:27 am | Drug Discovery & Development | Product Releases | Comments

Aushon’s multiplex technology has been shown to perform as well as the ELISA, while providing all the other benefits of a next-generation, multiplex platform including convenience, reduced sample consumption, higher throughput, and lower cost performance.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.